Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 166   

Articles published

GSK 1,352.00 -3.00 (-0.22%)
price chart
The Best Way To Play The Looming Superbug Threat [GlaxoSmithKline plc ...
biotech Tony Daltorio: Jim O'Neill, the former chief economist at Goldman Sachs, is best known for coining the BRIC acronym, which stands for the emerging market countries Brazil, Russia, India and China.
Jim Cramer Advises His Viewers On GlaxoSmithKline, American International ...
On CNBC's Mad Money, Jim Cramer said that GlaxoSmithKline plc (ADR) (NYSE: GSK) is not doing well. He can't recommend it and he would rather buy Regeneron Pharmaceuticals Inc (NASDAQ: REGN).
GlaxoSmithKline plc given 31% Potential Upside Indicated by Barclays Capital
GlaxoSmithKline plc with EPIC LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' this morning by analysts at Barclays Capital.
Barclays Reaffirms Overweight Rating for GlaxoSmithKline plc (GSK)  Dakota Financial News
GlaxoSmithKline plc Given Average Recommendation of "Hold" by ...  sleekmoney
GlaxoSmithKline PLC Mepolizumab treatment approved by US FDA Advisory ...
GlaxoSmithKline plc LON:GSK this morning announced the outcome of the meeting of the Pulmonary Allergy Drugs Advisory Committee of the United States (US) Food and Drug Administration (FDA) regarding the Biologics Licence Application (BLA) for ...
GlaxoSmithKline plc (ADR) Wins FDA Panel Backing For Severe Asthma Drug  Bidness ETC
FDA panel backs approval of GSK asthma drug in adults  Yahoo News
GlaxoSmithKline PLC (NYSE:GSK) Analyst Rating Update
Glaxosmithkline Plc (NYSE:GSK) has received a short term rating of strong sell from research analysts at Zacks with a rank of 5. The company has been rated an average of 2.63 by 8 Wall Street Analysts.
Here's How Pfizer Inc., GlaxoSmithKline plc Vaccines Deal Works For Both ...
Pfizer Inc. (NYSE:PFE) has decided to acquire two meningitis vaccines from GlaxoSmithKline plc (ADR) (NYSE:GSK) for about $130 million.
Pfizer to Acquire Two Meningitis Vaccines From GlaxoSmithKline  Wall Street Journal
Pfizer buying 2 meningitis vaccines from GlaxoSmithKline for $130 million  Economic Times
GlaxoSmithKline plc. (ADR) (NYSE:GSK) All Ready to Fund a New Institute in ...
It was announced by GlaxoSmithKline plc. (ADR) (NYSE:GSK) that the company will be investing $95 million for the purpose of establishing a research institute by the name of Altius Institute for Biomedical Sciences in Seattle.
GlaxoSmithKline plc (ADR) Committed To New Drug Discovery; Will Invest $95 ...  Bidness ETC
Stock in Motion: GlaxoSmithKline PLC (NYSE:GSK)  Vanguard Tribune
Stocks with High ROA: Supernus Pharmaceuticals Inc (NASDAQ:SUPN ...
In the last 12 months, GlaxoSmithKline plc (ADR) (NYSE:GSK) generated 20.78% using assets of the company. Reuters provide figures showing that industry's suggest 12.74% and broadly in sector 8.32% seems favorable.
Is GlaxoSmithKline plc Headed Towards A Turnaround?
GlaxoSmithKline's troubles began in the first quarter of 2011 (1QFY11), following the loss of a major patent for a major drug.
GlaxoSmithKline plc Earns Underperform Rating from Credit Suisse (GSK)
Credit Suisse reaffirmed their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a report released on Friday.
Credit Suisse Reiterates "Underperform" Rating for GlaxoSmithKline ...  The Legacy